99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics (Q39844585)

15 September 2017

title

99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics (English)

1 reference

15 September 2017

1 reference

3

Young-Seung Kim

1 reference

15 September 2017

Jiyun Shi

1

1 reference

15 September 2017

Lijun Wang

2

1 reference

15 September 2017

Shizhen Zhai

4

1 reference

15 September 2017

Bing Jia

5

1 reference

15 September 2017

Fan Wang

6

1 reference

15 September 2017

Shuang Liu

7

1 reference

15 September 2017

publication date

30 May 2009

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

15 September 2017

published in

1 reference

15 September 2017

volume

36

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

1874-1884

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-009-1166-1

15 September 2017

exact match

0 references

cites work

Multimodality imaging of tumor integrin alphavbeta3 expression

1 reference

12 December 2020

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting

1 reference

12 December 2020

Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation

1 reference

12 December 2020

Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy

1 reference

12 December 2020

[99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression

1 reference

12 December 2020

Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting

1 reference

12 December 2020

Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging

1 reference

12 December 2020

Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer

1 reference

12 December 2020

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

1 reference

12 December 2020

Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging

1 reference

12 December 2020

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis

1 reference

12 December 2020

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

1 reference

12 December 2020

(90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy

1 reference

12 December 2020

Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides

1 reference

12 December 2020

Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer

1 reference

12 December 2020

Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy

1 reference

12 December 2020

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies

1 reference

12 December 2020

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs

1 reference

12 December 2020

Imaging of integrins as biomarkers for tumor angiogenesis

1 reference

12 December 2020

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

1 reference

12 December 2020

Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers

1 reference

12 December 2020

Imaging of angiogenesis: from microscope to clinic

1 reference

12 December 2020

Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer

1 reference

12 December 2020

Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide

1 reference

12 December 2020

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

1 reference

12 December 2020

Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers

1 reference

12 December 2020

Multimodality molecular imaging of tumor angiogenesis

1 reference

12 December 2020

99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression

1 reference

12 December 2020

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

1 reference

12 December 2020

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

1 reference

12 December 2020

microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)

1 reference

12 December 2020

Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.

1 reference

12 December 2020

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

1 reference

12 December 2020

How molecular imaging is speeding up antiangiogenic drug development

1 reference

12 December 2020

In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).

1 reference

12 December 2020

Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients

1 reference

12 December 2020

microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide

1 reference

12 December 2020

Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression

1 reference

12 December 2020

Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.

1 reference

12 December 2020

Labeling cyclic glycoprotein IIb/IIIa receptor antagonists with 99mTc by the preformed chelate approach: effects of chelators on properties of [99mTc]chelator-peptide conjugates

1 reference

12 December 2020

Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers

1 reference

12 December 2020

Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis

1 reference

12 December 2020

Molecular imaging of tumor angiogenesis

1 reference

12 December 2020

99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand

1 reference

12 December 2020

Has molecular and cellular imaging enhanced drug discovery and drug development?

1 reference

12 December 2020

Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide

1 reference

12 December 2020

Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer

1 reference

12 December 2020

Tumor angiogenesis targeting using imaging agents.

1 reference

12 December 2020

Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer

1 reference

12 December 2020

Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide

1 reference

12 December 2020

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Advances in anatomic, functional, and molecular imaging of angiogenesis

1 reference

12 December 2020

10.1007/S00259-009-1166-1

Identifiers

DOI

1 reference

15 September 2017

1 reference